Cell-specific characterization of the placental methylome is a research paper published in BMC Genomics (2021). On theSindex it has a DataRank of 0.757. It has been cited 155 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.757
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Institutes of Health
Grant: 1R01HD089713-01
Using 'omics to build an atlas of placental development and function across pregnancy
NICHD NIH HHS
Grant: R01 HD089713
FWCI
9.62
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 1 of Cell-specific characterization of the placental methylome
Additional file 1 of Cell-specific characterization of the placental methylome
Cell-specific characterization of the placental methylome
Additional file 2 of Cell-specific characterization of the placental methylome
Additional file 2 of Cell-specific characterization of the placental methylome
Additional file 1 of A cross-cohort analysis of autosomal DNA methylation sex differences in the term placenta
Additional file 1 of A cross-cohort analysis of autosomal DNA methylation sex differences in the term placenta
Additional file 13 of Betamethasone administration during pregnancy is associated with placental epigenetic changes with implications for inflammation
Additional file 13 of Betamethasone administration during pregnancy is associated with placental epigenetic changes with implications for inflammation
Additional file 14 of Betamethasone administration during pregnancy is associated with placental epigenetic changes with implications for inflammation
Additional file 14 of Betamethasone administration during pregnancy is associated with placental epigenetic changes with implications for inflammation
Additional file 15 of Betamethasone administration during pregnancy is associated with placental epigenetic changes with implications for inflammation
Additional file 15 of Betamethasone administration during pregnancy is associated with placental epigenetic changes with implications for inflammation
Additional file 1 of Betamethasone administration during pregnancy is associated with placental epigenetic changes with implications for inflammation
Additional file 1 of Betamethasone administration during pregnancy is associated with placental epigenetic changes with implications for inflammation
Additional file 2 of Betamethasone administration during pregnancy is associated with placental epigenetic changes with implications for inflammation
Additional file 2 of Betamethasone administration during pregnancy is associated with placental epigenetic changes with implications for inflammation
Additional file 3 of Betamethasone administration during pregnancy is associated with placental epigenetic changes with implications for inflammation
Additional file 3 of Betamethasone administration during pregnancy is associated with placental epigenetic changes with implications for inflammation
Additional file 7 of Betamethasone administration during pregnancy is associated with placental epigenetic changes with implications for inflammation